Demmer, Ryan T.; Wu, Chaoqi; Kim, John S.; Sun, Yifei; Balte, Pallavi; Cushman, Mary; Boyle, Rebekah; Tracy, Russell P.; Styer, Linda M.; Bell, Taison D.; Anderson, Michaela R.; Allen, Norrina B.; Schreiner, Pamela J.; Bowler, Russell; Schwartz, David A.; Lee, Joyce S.; Xanthakis, Vanessa; Rock, Jean M.; Bievenue, Rachel; Pirzada, Amber; Doyle, Margaret; Regan, Elizabeth A.; Make, Barry J.; Kanaya, Alka M.; Kandula, Namratha R.; Wenzel, Sally E.; Coresh, Josef; Isasi, Carmen R.; Raffield, Laura M.; Elkind, Mitchell S., V; Howard, Virginia J.; Ortega, Victor E.; Woodruff, Prescott; Cole, Shelley A.; Henderson, Joel M.; Mantis, Nicholas J.; Oelsner, Elizabeth C.

Inter-laboratory harmonization of microsphere immunoassays for SARS-CoV-2 antibody detection in contrived dried blood spots and oral fluids

MICROBIOLOGY SPECTRUM

IF3.8

2025-03-010

OAAI

Antibody signatures elicited by potent and subpotent whole-cell pertussis vaccines in mice

MICROBIOLOGY SPECTRUM

IF3.8

2025-03-010

OAAI

A type-specific B-cell epitope at the apex of outer surface protein C (OspC) of the Lyme disease spirochete, Borreliella burgdorferi

MICROBIOLOGY SPECTRUM

IF3.8

2025-02-140

OAAI

PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2025-02-040

OAAI

Quantitating SARS-CoV-2 neutralizing antibodies from human dried blood spots

MICROBIOLOGY SPECTRUM

IF3.8

2024-12-050

OAAI

Structure of a Human Monoclonal Antibody in Complex with Outer Surface Protein C of the Lyme Disease Spirochete, Borreliella burgdorferi

JOURNAL OF IMMUNOLOGY

IF3.4

2024-09-061

Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges

VACCINES

IF3.4

2024-06-031

OAAI

Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study

NATURE COMMUNICATIONS

IF15.7

2024-02-195

OAAI

Kim, John S.; Sun, Yifei; Balte, Pallavi; Cushman, Mary; Boyle, Rebekah; Tracy, Russell P.; Styer, Linda M.; Bell, Taison D.; Anderson, Michaela R.; Allen, Norrina B.; Schreiner, Pamela J.; Bowler, Russell P.; Schwartz, David A.; Lee, Joyce S.; Xanthakis, Vanessa; Doyle, Margaret F.; Regan, Elizabeth A.; Make, Barry J.; Kanaya, Alka M.; Wenzel, Sally E.; Coresh, Josef; Isasi, Carmen R.; Raffield, Laura M.; Elkind, Mitchell S. V.; Howard, Virginia J.; Ortega, Victor E.; Woodruff, Prescott; Cole, Shelley A.; Henderson, Joel M.; Mantis, Nicholas J.; Parker, Monica M.; Demmer, Ryan T.; Oelsner, Elizabeth C.

Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination

CLINICAL CHEMISTRY

IF6.3

2023-12-013

OAAI

Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2023-11-061

OAAI

An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretions

CELL REPORTS MEDICINE